Caitong International Asset Management Co., LTD Moon Lake Immunotherapeutics Transaction History
Caitong International Asset Management Co., LTD
- $134 Billion
- Q1 2025
A detailed history of Caitong International Asset Management Co., LTD transactions in Moon Lake Immunotherapeutics stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 147 shares of MLTX stock, worth $5,530. This represents 0.0% of its overall portfolio holdings.
Number of Shares
147Holding current value
$5,530% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding MLTX
# of Institutions
161Shares Held
55.3MCall Options Held
481KPut Options Held
229K-
Bvf Inc San Francisco, CA19.8MShares$743 Million33.91% of portfolio
-
Cormorant Asset Management, LP Boston, MA8.49MShares$320 Million35.2% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.97MShares$112 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.77MShares$104 Million1.75% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.48MShares$55.6 Million0.01% of portfolio
About MoonLake Immunotherapeutics
- Ticker MLTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,925,600
- Market Cap $1.39B
- Description
- MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...